A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.
Candiota AP, Acosta M, Simões RV, Delgado-Goñi T, Lope-Piedrafita S, Irure A, Marradi M, Bomati-Miguel O, Miguel-Sancho N, Abasolo I, Schwartz S Jr, Santamaria J, Penadés S, Arús C.
Candiota AP, et al. Among authors: delgado goni t.
J Nanobiotechnology. 2014 Apr 5;12:12. doi: 10.1186/1477-3155-12-12.
J Nanobiotechnology. 2014.
PMID: 24708566
Free PMC article.